Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
startups
Biotech
cAMPfield harvests $180M series A to advance oral IBD asset
The money will help advance cAMPfield’s lead candidate, an oral PDE4 inhibitor licensed from China’s Newsoara, for the treatment of IBD.
Angus Liu
Jun 18, 2026 10:34am
Nortiva purrs into action with long-acting Lynx platform
Jun 18, 2026 8:00am
New Flagship biotech circles in on new DNA drug class
Apr 21, 2026 6:30am
VC firm to open 30K-square-foot incubator in Salt Lake City
Mar 5, 2026 10:00am
How Biohaven is keeping its 'feet to the fire'
Feb 20, 2026 10:30am
Outpatient surgery startup Oath Surgical inks Nvidia partnership
Jan 27, 2026 9:00am